Hospitals could advance these tests as Laboratory Developed Tests or LDTs, meaning they develop them in house. But since HHS declared a public health emergency related to #Coronavirus, hospitals are now expected to get FDA permission to use their own testshttps://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/information-laboratories-implementing-ivd-tests-under-eua …
-
-
Prikaži ovu nit
-
Following the public health emergency declaration, HHS is expected to issue a declaration justifying Emergency Use Authorization (EUA) to facilitate the development of diagnostics and therapeutics for
#Coronavirushttps://www.medtechdive.com/news/amid-coronavirus-outbreak-fda-and-industry-seek-roadmap-for-emergency-diag/571418/ …Prikaži ovu nit -
LDTs for
#Coronavirus would be considered to be “developed to diagnose serious or life-threatening diseases or conditions” and for “analyses of disease progression and public health decision making” per FDA guidelines and expected to get EUAs. So herein lies the Catch-22Prikaži ovu nit -
We need to expand screening capability; the CDC lab that is currently sanctioned to run all these tests is taking 36-48 hours to turn around results. Moreover, it will be quickly overwhelmed in an outbreak. https://www.wsj.com/articles/new-york-city-investigating-possible-first-case-of-coronavirus-11580596507?emailToken=f2c8204e72c7261ca6160be8873271f7wII7Nuc7ExnH+n8CEyFWY5l8/De7ieO1LEk2Ytpq6WdRbQuCOcqyLE19FrTThX0QOB9FO140HGpuLTCY8Dd2RJrhAsKnfIxg47NrV1lifOVYsP8D9yrZDMmKKwKx1Q7w&reflink=article_imessage_share …pic.twitter.com/jJ3pmJggMZ
Prikaži ovu nit -
We also should expand triggers for screening to detect outbreaks early. Anyone with atypical viral pneumonia where multiplex respiratory viral panel is negative should probably be checked for
#nCoV; not just those returning from China. But we don’t have screening capacity nowpic.twitter.com/PngAjZI5tE
Prikaži ovu nit -
Since CDC and FDA haven’t authorized public health or hospital labs to run the tests, right now
#CDC is the only place that can. So, screening has to be rationed. Our ability to detect secondary spread among people not directly tied to China travel is greatly limited.Prikaži ovu nit -
Systems to run RT-PCR are well established. It’s run on Roche Diagnostics platform, a system every hospital lab has. Labs run thousands of such tests daily for broad range of viruses. They're technically straightforward and reliable if sample prep is good https://www.ncbi.nlm.nih.gov/pubmed/11884626
Prikaži ovu nit -
#FDA and#CDC can allow more labs to run the RT-PCR tests starting with public health agencies. Big medical centers can also be authorized to run tests under EUA. For now they're not permitted to run the tests, even though many labs can do so reliably 9/9 https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html …pic.twitter.com/e0OjguH5NR
Prikaži ovu nit -
Note: Thermo Fischer also makes a commonly-used RT-PCR platform https://thermofisher.com/us/en/home/life-science/pcr/real-time-pcr.html?SID=fr-pcr-1 … as does Qiagen https://qiagen.com/us/products/discovery-and-translational-research/pcr-qpcr/qpcr-assays-and-instruments/pcr-instruments/?q=%3aimportance%3acategory%3apcr-instruments …, among others, and in addition to Roche. Cepheid makes a platform called GeneXpert for performing RT-PCR at the point of care https://cepheid.com pic.twitter.com/gqEgL2c9aN
Prikaži ovu nit
Kraj razgovora
Novi razgovor -
-
-
Is PCR test accurate?
@CDCDirector's comments at@WhiteHouse briefing: "[For those hospitalized], we've seen people that have detectable#coronavirus. Then they didn't have the detectable virus. And then three days later they had detectable virus" https://twitter.com/manal_mehta/status/1223865506517487616?s=20 …@rtnarch
-
Is the issue test capacity or test accuracy?
@WHO guidance suggests repeat tests until minimum 24 hour period of clearance between tests - which is different than CDC's position.@CDCgov & WHO need to get on the same page. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2 …#coronavirus#nCov2019pic.twitter.com/xLklSD8awK
Kraj razgovora
Novi razgovor -
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.